title: Dyslipidaemia: Predicting the benefits and risks of PCSK9 inhibition.
authors.forename: David
authors.initials: D
authors.lastname: Holmes
mesh_terms: D050171:Dyslipidemias; D006801:Humans; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D018570:Risk Assessment; D012697:Serine Endopeptidases
chemical_list: D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases